Inhaled corticosteroids and risk of fractures

被引:0
|
作者
Van Staa, TP
Leufkens, H
Cooper, C
机构
[1] Univ Utrecht, NL-3508 TC Utrecht, Netherlands
[2] MRC, Southampton, Hants, England
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:S113 / S113
页数:1
相关论文
共 50 条
  • [21] INHALED CORTICOSTEROIDS IN CHILDHOOD - RISK AND BENEFIT
    MARTINATI, LC
    BONER, AL
    RIVISTA ITALIANA DI PEDIATRIA-ITALIAN JOURNAL OF PEDIATRICS, 1995, 21 (01): : 16 - 29
  • [22] Inhaled Corticosteroids in Asthma and the Risk of Pneumonia
    Kim, Min-Hye
    Rhee, Chin Kook
    Shim, Ji-Su
    Park, So Young
    Yoo, Kwang Ha
    Kim, Bo Yeon
    Bae, Hye Won
    Sim, Yun Su
    Chang, Jung Hyun
    Cho, Young-Joo
    Lee, Jin Hwa
    ALLERGY ASTHMA & IMMUNOLOGY RESEARCH, 2019, 11 (06) : 795 - 805
  • [23] The effects of inhaled corticosteroids on risk of self-reported osteoporosis and fractures in adult subjects with asthma
    Corsico, Angelo Guido
    Grosso, Amelia
    Cazzoletti, Lucia
    Mattioli, Veronica
    Albicini, Federica
    Gini, Erica
    Zanolin, Elisabetta
    Cerveri, Isa
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [24] INHALED CORTICOSTEROIDS FOR COPD Risk-benefit profile of inhaled corticosteroids in COPD is still unclear
    Turgeon, Ricky D.
    Tejani, Aaron M.
    BMJ-BRITISH MEDICAL JOURNAL, 2012, 345
  • [25] The use of inhaled corticosteroids and the risk of adrenal insufficiency
    Lapi, Francesco
    Kezouh, Abbas
    Suissa, Samy
    Ernst, Pierre
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42 (01) : 79 - 86
  • [26] Inhaled Corticosteroids Is Not Associated with the Risk of Pneumonia in Asthma
    Lee, Ye Jin
    Park, Yong-Bum
    TUBERCULOSIS AND RESPIRATORY DISEASES, 2023, 86 (03) : 151 - 157
  • [27] Inhaled corticosteroids, family history, and risk of glaucoma
    Mitchell, P
    Cumming, RG
    Mackey, DA
    OPHTHALMOLOGY, 1999, 106 (12) : 2301 - 2306
  • [29] Inhaled corticosteroids and the risk of diabetes among the elderly
    Dendukuri, N
    Blais, L
    LeLorier, J
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 54 (01) : 59 - 64